| Stage | AXON | % of rev | RGR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $904M | 100.00% | $148M | 100.00% | AXON ×6.13 |
| Gross profit | $546M | 60.42% | $31M | 20.68% | AXON +39.7pp |
| Operating income | $47M | 5.17% | $6M | 4.05% | AXON +1.1pp |
| Pre-tax income | $33M | 3.61% | $8M | 5.11% | RGR +1.5pp |
| Net income | $29M | 3.25% | $6M | 3.93% | RGR +0.7pp |
| Stage | AXON | RGR | Gap · A − B |
|---|---|---|---|
| Revenue | $904M100.00% | $148M100.00% | AXON ×6.13 |
| Gross profit | 60.42%$546M | 20.68%$31M | AXON +39.7pp |
| Operating income | 5.17%$47M | 4.05%$6M | AXON +1.1pp |
| Pre-tax income | 3.61%$33M | 5.11%$8M | RGR +1.5pp |
| Net income |
| 3.25%$29M |
| 3.93%$6M |
| RGR +0.7pp |
No disclosed counterparties: AXON, RGR.